BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31885007)

  • 21. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
    Niino M; Ogata A; Kikuchi S; Tashiro K; Nishihira J
    J Neurol Sci; 2000 Oct; 179(S 1-2):127-31. PubMed ID: 11054496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
    Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.
    Maghrebi O; Belghith M; Jeridi C; Rachdi A; Fatnassi FN; Saied Z; Belal S; Ben Sassi S; Barbouche MR
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Headache in Behçet's and Neuro-Behçet's Disease.
    Beton OE; Yucesan C
    Neurol India; 2022; 70(1):254-257. PubMed ID: 35263891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
    Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement.
    Hamzaoui K; Ayed K; Hamza M; Hamzaoui A
    J Neuroimmunol; 2009 Aug; 213(1-2):148-53. PubMed ID: 19493574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.
    Akman-Demir G; Tüzün E; Içöz S; Yeşilot N; Yentür SP; Kürtüncü M; Mutlu M; Saruhan-Direskeneli G
    Cytokine; 2008 Dec; 44(3):373-6. PubMed ID: 19010690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases.
    Saruhan-Direskeneli G; Yentür SP; Akman-Demir G; Işik N; Serdaroğlu P
    J Neuroimmunol; 2003 Dec; 145(1-2):127-34. PubMed ID: 14644038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.
    Ugurel E; Erdag E; Kucukali CI; Olcay A; Sanli E; Akbayir E; Kurtuncu M; Gunduz T; Yilmaz V; Tuzun E; Vural B
    In Vivo; 2019; 33(5):1493-1497. PubMed ID: 31471397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease.
    Saruhan-Direskeneli G; Yentür SP; Mutlu M; Shugaiv E; Yesilot N; Kürtüncü M; Akman-Demir G
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):25-7. PubMed ID: 23558092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent aspects of Neuro-Behcet's disease].
    Hirohata S
    Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
    Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
    Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF levels of cytokines in neuro-Behçet's disease.
    Borhani Haghighi A; Ittehadi H; Nikseresht AR; Rahmati J; Poorjahromi SG; Pourabbas B; Nazarinia MA; Habibagahi Z; Fattahi MJ; Ghaderi A
    Clin Neurol Neurosurg; 2009 Jul; 111(6):507-10. PubMed ID: 19303205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudotumoral neuro-behcet's disease: case series and review of literature.
    Hadj Taieb MA; Slimane H; Mhiri M; Ben Dhia R; Daoussi N; Frih-Ayed M
    Acta Neurol Belg; 2024 Apr; 124(2):431-445. PubMed ID: 38396190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome.
    Wang CR; Chuang CY; Chen CY
    Clin Exp Rheumatol; 1992; 10(6):599-602. PubMed ID: 1483312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional Status in patients with Neuro-Behçet's disease.
    Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
    Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome.
    Kawai M; Hirohata S
    J Neurol Sci; 2000 Oct; 179(S 1-2):132-9. PubMed ID: 11054497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.